Printer Friendly

Xcelience Adds Piccola B10 Minipress for GMP Tablet Formulation Development in Experimental Area.

TAMPA, Fla. -- Xcelience, a leader in early drug contract development, has expanded formulation development and manufacturing capabilities to include a Piccola B10 Minipress. This 10-station table top rotary tablet press enables clients to make an early assessment of how the developed process and formula will perform in production, which can shorten development time and lead to early identification and resolution of potential formulation issues. The ability to cost-effectively produce small batch sizes in the experimental area while obtaining all of the necessary processing parameters is an additional advantage.

Equipped with a data acquisition and analysis system (The Director Software V4 Scalability Program), the Piccola B10 Minipress provides clients with detailed analysis such as compaction profiles, strain rate studies, single compaction event investigation and statistical analysis of each production run.

"Adding a bench scale tablet press in the experimental area is consistent with our strategy of providing equipment appropriately scaled to the needs of our clients," says Paul Skultety, Ph.D., Director of Pharmaceutical Development Services. "The Piccola scales nicely to our existing Fette 1200i instrumented press in our cGMP manufacturing area, and helps clients build towards improved manufacturing outcomes in a manner consistent with the FDA's Quality by Design initiative."

Xcelience is a contract research organization providing formulation development, preformulation, analytical, and clinical trial manufacturing to American and European companies since 1997. The company is renowned for reliably expediting early development activities to speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. Xcelience's unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the Xcelience lab. For more detailed information about Xcelience, visit .
COPYRIGHT 2010 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U5FL
Date:Aug 11, 2010
Previous Article:Interactive Data Now Offers Expanded Bond Analytics Capabilities in RemotePlus.
Next Article:Pilgrim Software Appoints Agaram Industries (P) Ltd as Strategic Reseller for the India Market.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters